Published Version
Open DOI LinkAbstract
Interstitial lung diseases (ILDs), which can arise from a broad spectrum of distinct aetiologies, can manifest as a pulmonary complication of an underlying autoimmune and connective tissue disease (CTD-ILD), such...
Full Text
Open DOI Link
Sign-in/Register to access full text options Topics from this Paper
Efficacy In Idiopathic Pulmonary Fibrosis- Progressive Phenotype
- Interstitial Lung Diseases
- Tyrosine Kinase Inhibitor Nintedanib
- Idiopathic Pulmonary Fibrosis + Show 5 more
Create a personalized feed of these topics
Get StartedTalk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Chronic fibrosing interstitial lung diseases according to the register of Irkutsk (Russia) 
Relevant
Not Relevant
PULMONOLOGIYA
Apr 30, 2022
RelevantNot Relevant Progressive fibrotic interstitial lung disease. RelevantNot Relevant
- Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia
- Jul 24, 2023
RelevantNot Relevant Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA RelevantNot Relevant
- Advances in Therapy
- May 21, 2020
RelevantNot Relevant Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be RelevantNot Relevant
- Journal of Clinical Medicine
- Mar 23, 2021
RelevantNot Relevant Natural history of systemic sclerosis–related interstitial lung disease: How to identify a progressive fibrosing phenotype RelevantNot Relevant
- Journal of Scleroderma and Related Disorders
- Dec 5, 2019
RelevantNot Relevant Care patterns of patients with chronic fibrosing interstitial lung disease (ILD) with a progressive phenotype RelevantNot Relevant
- BMC Pulmonary Medicine
- Apr 23, 2022
RelevantNot Relevant Progressive Fibrosing Interstitial Lung Diseases: A Current Perspective RelevantNot Relevant
- Biomedicines
- Sep 16, 2021
RelevantNot Relevant PH-ILD: Identification, Evaluation, and Monitoring: A Diagnostic View From Both Sides RelevantNot Relevant
- Advances in Pulmonary Hypertension
- Oct 1, 2021
RelevantNot Relevant Endotype–phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease RelevantNot Relevant
- EBioMedicine
- Dec 1, 2019
RelevantNot Relevant Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study) RelevantNot Relevant
- European Respiratory Journal
- Sep 17, 2020
RelevantNot Relevant Lung transplantation for interstitial lung disease in idiopathic inflammatory myositis: A cohort study RelevantNot Relevant
- American Journal of Transplantation
- Dec 1, 2022
RelevantNot Relevant Epidemiology and real-life experience in progressive pulmonary fibrosis RelevantNot Relevant
- Current Opinion in Pulmonary Medicine
- Sep 1, 2022
RelevantNot Relevant Induction of connective tissue growth factor accounts for the inability of glucocorticoid suppression on pulmonary fibrosis RelevantNot Relevant
- Clinical and Translational Medicine
- May 1, 2022
RelevantNot Relevant Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials RelevantNot Relevant
- The Lancet Rheumatology
- Oct 1, 2022
RelevantNot RelevantREAD MORE FROMAnnals of the Rheumatic Diseases
Clonal haematopoiesis across the age spectrum of vasculitis patients with Takayasu’s arteritis, ANCA-associated vasculitis and giant cell arteritis 
Just PublishedRelevantNot Relevant
Just Published- Annals of the Rheumatic Diseases
- Nov 29, 2023
RelevantNot Relevant In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation Just PublishedRelevantNot Relevant
Just Published- Annals of the Rheumatic Diseases
- Nov 27, 2023
RelevantNot Relevant Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways Just PublishedRelevantNot Relevant
Just Published- Annals of the Rheumatic Diseases
- Nov 24, 2023
RelevantNot Relevant Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis 
Open AccessJust PublishedRelevantNot Relevant
Open AccessJust Published- Annals of the Rheumatic Diseases
- Nov 24, 2023
RelevantNot Relevant 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases Open AccessJust PublishedRelevantNot Relevant
Open AccessJust Published- Annals of the Rheumatic Diseases
- Nov 22, 2023
RelevantNot Relevant Subclinical inflammation and joint damage progression in patients with early RA fulfilling 2011 vs 2022 ACR/EULAR Boolean remission criteria: data from the ARCTIC study Just PublishedRelevantNot Relevant
Just Published- Annals of the Rheumatic Diseases
- Nov 22, 2023
RelevantNot Relevant Response to: Correspondence on ‘2023 ACR/EULAR antiphospholipid syndrome classification criteria’ by Tang et al Open AccessJust PublishedRelevantNot Relevant
Open AccessJust Published- Annals of the Rheumatic Diseases
- Nov 21, 2023
RelevantNot Relevant Response to: Correspondence on ‘ACR/EULAR antiphospholipid syndrome classification criteria’ by Damoiseaux and van Beers Open AccessJust PublishedRelevantNot Relevant
Open AccessJust Published- Annals of the Rheumatic Diseases
- Nov 21, 2023
RelevantNot Relevant Response to: Correspondence on ‘2023 ACR/EULAR antiphospholipid syndrome classification criteria’ by Miro-Mur et al Open AccessJust PublishedRelevantNot Relevant
Open AccessJust Published- Annals of the Rheumatic Diseases
- Nov 21, 2023
RelevantNot Relevant Improving the nosology of Long COVID: it is not so simple Just PublishedRelevantNot Relevant
Just Published- Annals of the Rheumatic Diseases
- Nov 21, 2023
RelevantNot Relevant